Source: BUSINESS WIRE

Press Release: Aryogen : Research and Markets: Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight Report

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/j3z6g5/non_hodgkin) has announced the addition of the "Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight" report to their offering. The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment. Past few deca

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Mohammad Saffarioun's photo - CEO of AryoGen Pharmed

CEO

Mohammad Saffarioun

CEO Approval Rating

67/100

Read more